165 related articles for article (PubMed ID: 12015837)
1. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
Hoh BL; Carter BS; Ogilvy CS
Neurosurgery; 2002 Jun; 50(6):1207-11; discussion 1211-2. PubMed ID: 12015837
[TBL] [Abstract][Full Text] [Related]
2. Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe?
Platz J; Güresir E; Vatter H; Berkefeld J; Seifert V; Raabe A; Beck J
Neurocrit Care; 2011 Apr; 14(2):168-75. PubMed ID: 21286853
[TBL] [Abstract][Full Text] [Related]
3. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms.
Reynolds MR; Buckley RT; Indrakanti SS; Turkmani AH; Oh G; Crobeddu E; Fargen KM; El Ahmadieh TY; Naidech AM; Amin-Hanjani S; Lanzino G; Hoh BL; Bendok BR; Zipfel GJ
J Neurosurg; 2015 Oct; 123(4):862-71. PubMed ID: 26207606
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms.
Bernardini GL; Mayer SA; Kossoff SB; Hacein-Bey L; Solomon RA; Pile-Spellman J
Crit Care Med; 2001 Mar; 29(3):641-4. PubMed ID: 11373436
[TBL] [Abstract][Full Text] [Related]
6. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.
Miller JA; Dacey RG; Diringer MN
Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and long-term outcomes in patients with ruptured posterior inferior cerebellar artery aneurysms: a comparative analysis.
Williamson RW; Wilson DA; Abla AA; McDougall CG; Nakaji P; Albuquerque FC; Spetzler RF
J Neurosurg; 2015 Aug; 123(2):441-5. PubMed ID: 25884260
[TBL] [Abstract][Full Text] [Related]
9. Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage.
Frontera JA; Fernandez A; Schmidt JM; Claassen J; Wartenberg KE; Badjatia N; Connolly ES; Mayer SA
Neurosurgery; 2010 Jan; 66(1):35-41; discussion 41. PubMed ID: 20023535
[TBL] [Abstract][Full Text] [Related]
10. Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome.
Taha MM; Nakahara I; Higashi T; Iwamuro Y; Iwaasa M; Watanabe Y; Tsunetoshi K; Munemitsu T
Surg Neurol; 2006 Sep; 66(3):277-84; discussion 284. PubMed ID: 16935636
[TBL] [Abstract][Full Text] [Related]
11. Neurological outcomes following intraprocedural rerupture during coil embolization of ruptured intracranial aneurysms.
Stapleton CJ; Walcott BP; Butler WE; Ogilvy CS
J Neurosurg; 2015 Jan; 122(1):128-35. PubMed ID: 25361491
[TBL] [Abstract][Full Text] [Related]
12. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage.
Solomon RA; Fink ME; Lennihan L
Neurosurgery; 1988 Dec; 23(6):699-704. PubMed ID: 3216966
[TBL] [Abstract][Full Text] [Related]
13. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow.
Joseph M; Ziadi S; Nates J; Dannenbaum M; Malkoff M
Neurosurgery; 2003 Nov; 53(5):1044-51; discussion 1051-2. PubMed ID: 14580270
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
[TBL] [Abstract][Full Text] [Related]
15. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].
Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA
Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430
[TBL] [Abstract][Full Text] [Related]
16. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage.
Qureshi AI; Suarez JI; Bhardwaj A; Yahia AM; Tamargo RJ; Ulatowski JA
Crit Care Med; 2000 Mar; 28(3):824-9. PubMed ID: 10752836
[TBL] [Abstract][Full Text] [Related]
17. Coadjuvant Treatment of Vasospasm in Ruptured Unsecured Cerebral Aneurysms with Aggressive Angioplasty, Intra-Arterial Nimodipine, and Aneurysm Embolization.
Chen CC; Yi-Chou Wang A; Chen CT; Hsieh PC
World Neurosurg; 2018 Aug; 116():e452-e459. PubMed ID: 29753899
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting rapid growth of unruptured cerebral aneurysms during the acute stage of subarachnoid hemorrhage.
Anda T; Yonekura M; Baba H; Suyama K; Toda K; Kamada K; Ono T; Yoshida K; Baba S; Onizuka M
Neurol Res; 2006 Mar; 28(2):165-71. PubMed ID: 16551434
[TBL] [Abstract][Full Text] [Related]
19. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
20. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
